Literature DB >> 14499779

Risk of congenital abnormalities in children born to women with ulcerative colitis: a population-based, case-control study.

Bente Nørgård1, Erzsebet Puho, Lars Pedersen, Andrew E Czeizel, Henrik T Sørensen.   

Abstract

OBJECTIVES: It has recently been suggested that maternal ulcerative colitis is associated with an almost 4-fold increased risk of congenital abnormalities in offspring. We therefore examined the risk of congenital abnormalities in children born to women with ulcerative colitis.
METHODS: This was a case-control study within the Hungarian Case Control Surveillance of Congenital Abnormalities, 1980-1996, based on 22,843 newborn children or fetuses with congenital abnormalities and 38,151 children without any detected congenital abnormalities (the control group).
RESULTS: Seventy-one pregnant women (0.3%) had ulcerative colitis in the case group and 95 (0.2%) in the control group. The adjusted overall risk for having a child with congenital abnormalities in women with ulcerative colitis was OR = 1.3 (95% CI = 0.9-1.8). The risk of limb deficiencies, obstructive urinary congenital abnormalities, and multiple congenital abnormalities was OR = 6.2 (95% CI = 2.9-13.1), OR = 3.3 (95% CI = 1.1-9.5), and OR = 2.6 (95% CI = 1.3-5.4), respectively. No association was found for cleft lip with or without cleft palate or cardiovascular defects.
CONCLUSIONS: We found no significantly increased overall risk of congenital abnormalities in children born to women with ulcerative colitis. However, our results indicate an increased risk of some selected congenital abnormalities (limb deficiencies, obstructive urinary congenital abnormalities, and multiple congenital abnormalities). More data are needed to determine whether the association between maternal ulcerative colitis and an increased risk of certain congenital abnormalities is causal or is influenced by bias.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14499779     DOI: 10.1111/j.1572-0241.2003.07578.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  15 in total

Review 1.  Drug therapy for ulcerative colitis.

Authors:  Chang-Tai Xu; Shu-Yong Meng; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

Review 2.  Fertility and pregnancy in the patient with inflammatory bowel disease.

Authors:  U Mahadevan
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

Review 3.  A meta-analysis on the influence of inflammatory bowel disease on pregnancy.

Authors:  J Cornish; E Tan; J Teare; T G Teoh; R Rai; S K Clark; P P Tekkis
Journal:  Gut       Date:  2006-12-21       Impact factor: 23.059

4.  Inflammatory bowel disease in pregnancy.

Authors:  Dawn B Beaulieu; Sunanda Kane
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 5.  Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease.

Authors:  Ioannis Androulakis; Christos Zavos; Panagiotis Christopoulos; George Mastorakos; Maria Gazouli
Journal:  World J Gastroenterol       Date:  2015-12-21       Impact factor: 5.742

6.  Gastrointestinal Conditions during Pregnancy.

Authors:  Sherri A Longo; Robert C Moore; Bernard J Canzoneri; Alfred Robichaux
Journal:  Clin Colon Rectal Surg       Date:  2010-06

Review 7.  Pregnancy related issues in inflammatory bowel disease: evidence base and patients' perspective.

Authors:  Christian P Selinger; Rupert Wl Leong; Simon Lal
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

Review 8.  Tumor necrosis factor-α inhibitor therapy and fetal risk: a systematic literature review.

Authors:  Renée M Marchioni; Gary R Lichtenstein
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

Review 9.  From conception to delivery: managing the pregnant inflammatory bowel disease patient.

Authors:  Vivian W Huang; Flavio M Habal
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

10.  Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes.

Authors:  Heather A Boyd; Saima Basit; Maria C Harpsøe; Jan Wohlfahrt; Tine Jess
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.